FINLIUS I.V.

Google image searchProduct monograph

Active ingredient

ustekinumab, 5 MG/ML

DIN: 02537311

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE VIAL

Schedule: Prescription / Schedule D

Company: JANSSEN INC

Date: 02-JUL-2024

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AC — Interleukin inhibitors (ATC, ATC/DDD)
• L04AC05 — USTEKINUMAB (ATC/DDD)

Reference brand drug: Stelara

Pharmaceutical standard: MFR

External Links for Finlius I.v.

Search on Google

• Finlius I.v. side effects
• Finlius I.v. dosage
• ustekinumab side effects
• ustekinumab dosage

Janssen Inc

Go to Janssen website to see drug product details. Sometimes you can find finlius i.v. photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.